GNLY | Granulysin | Predicted intracellular proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
GP1BA | Glycoprotein Ib (platelet), alpha polypeptide | CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
GP9 | Glycoprotein IX (platelet) | CD markers Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
GRAP2 | GRB2-related adaptor protein 2 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
GZMK | Granzyme K (granzyme 3; tryptase II) | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
HIST1H2AB | Histone cluster 1, H2ab | Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST1H2AD | Histone cluster 1, H2ad | Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST1H2AI | Histone cluster 1, H2ai | Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST1H2AJ | Histone cluster 1, H2aj | Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST1H2AM | Histone cluster 1, H2am | Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST1H2BE | Histone cluster 1, H2be | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST1H2BI | Histone cluster 1, H2bi | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST1H2BM | Histone cluster 1, H2bm | Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST1H2BO | Histone cluster 1, H2bo | Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST1H3C | Histone cluster 1, H3c | Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST1H3D | Histone cluster 1, H3d | Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST1H3F | Histone cluster 1, H3f | Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST1H3I | Histone cluster 1, H3i | Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST1H3J | Histone cluster 1, H3j | Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST1H4A | Histone cluster 1, H4a | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST1H4B | Histone cluster 1, H4b | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST1H4F | Histone cluster 1, H4f | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST1H4J | Histone cluster 1, H4j | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST2H2AB | Histone cluster 2, H2ab | Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST2H2AC | Histone cluster 2, H2ac | Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST2H3PS2 | Histone cluster 2, H3, pseudogene 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
HK3 | Hexokinase 3 (white cell) | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
HMGA2 | High mobility group AT-hook 2 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
HMHA1 | Histocompatibility (minor) HA-1 | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
IDO1 | Indoleamine 2,3-dioxygenase 1 | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
IGSF21 | Immunoglobin superfamily, member 21 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
IKZF1 | IKAROS family zinc finger 1 (Ikaros) | Cancer-related genes Disease related genes Predicted intracellular proteins Predicted membrane proteins Transcription factors
| | | | | Tissue enhanced |
IL2RA | Interleukin 2 receptor, alpha | Cancer-related genes CD markers Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
IL2RB | Interleukin 2 receptor, beta | Cancer-related genes CD markers FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
IL2RG | Interleukin 2 receptor, gamma | Cancer-related genes CD markers Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
IL4I1 | Interleukin 4 induced 1 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
ITGA2B | Integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ITGAL | Integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) | CD markers FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ITGAM | Integrin, alpha M (complement component 3 receptor 3 subunit) | Cancer-related genes CD markers Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ITGAX | Integrin, alpha X (complement component 3 receptor 4 subunit) | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
JAK3 | Janus kinase 3 | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
KIF18B | Kinesin family member 18B | Predicted intracellular proteins
| | | | | Tissue enhanced |
KIF21B | Kinesin family member 21B | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
KLRC3 | Killer cell lectin-like receptor subfamily C, member 3 | Predicted membrane proteins
| | | | | Tissue enhanced |
KLRK1 | Killer cell lectin-like receptor subfamily K, member 1 | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
LAG3 | Lymphocyte-activation gene 3 | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LAT | Linker for activation of T cells | Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
LCK | LCK proto-oncogene, Src family tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
LCN2 | Lipocalin 2 | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LEF1 | Lymphoid enhancer-binding factor 1 | Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |